A Safety and Efficacy Evaluation of Hemoglobin-Based Oxygen Carrier HBOC-201 in a Randomized, Multicenter Red Blood Cell Controlled Trial in Noncardiac Surgery Patients-Reference-Cited by-同舟云学术

A Safety and Efficacy Evaluation of Hemoglobin-Based Oxygen Carrier HBOC-201 in a Randomized, Multicenter Red Blood Cell Controlled Trial in Noncardiac Surgery Patients

Published:2014-10 Issue:4 Volume:119 Page:766-776
ISSN:0003-2999
Container-title:Anesthesia & Analgesia
language:en
Short-container-title:

Author:

Van Hemelrijck Jan,Levien Lewis J.,Veeckman Luc,Pitman Arkadiy,Zafirelis Zafiris,Standl Thomas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine

Reference27 articles.

1. HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery.;Jahr;J Trauma,2008

2. Randomization in clinical trials of titrated therapies: unintended consequences of using fixed treatment protocols.;Deans;Crit Care Med,2007

3. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis.;Natanson;JAMA,2008

4. Transfusion of older stored blood and risk of death: a meta-analysis.;Wang;Transfusion,2012

5. Old blood bad Either the biggest issue in transfusion medicine or a nonevent.;Warkentin;Transfusion,2012

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crystalloids, colloids, blood products and blood substitutes;Anaesthesia & Intensive Care Medicine;2022-05

2. The Use of Hemoglobin-Based Oxygen Carriers in Ex Vivo Machine Perfusion of Donor Organs for Transplantation;ASAIO Journal;2022-02-24

3. HBOC-201: History, Clinical Trials, and Path Forward;Blood Substitutes and Oxygen Biotherapeutics;2022

4. Complications of HBOCs Including Clinical Safety Issues;Blood Substitutes and Oxygen Biotherapeutics;2022

5. New Applications of HBOC-201: A 25-Year Review of the Literature;Frontiers in Medicine;2021-12-08